methylprednisolone and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
methylprednisolone has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 22 studies
Research
Studies (22)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (36.36) | 18.2507 |
2000's | 12 (54.55) | 29.6817 |
2010's | 2 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Cardarelli, L; Chiaretti, S; Diverio, D; Foà, R; Giona, F; Mancini, F; Miano, M; Moleti, ML; Nanni, M; Palumbo, G; Peragine, N; Santopietro, M; Testi, AM; Zhang, K | 1 |
Assa'ad, A; Burns, K; Hershey, GK; Johnson, T; Lierl, MB; Metz, KA; Seidu, L | 1 |
Chen, J; Shen, J; Zheng, Z; Zhou, Y | 1 |
Ayyildiz, O; Bolaman, Z; Demir, S; Kadiköylü, G; Köseoğlu, M; Müftüoğlu, E; Sönmez, HM | 1 |
Fujigaki, Y; Hishida, A; Isozaki, T; Ohashi, N; Sugiura, T; Togawa, A; Yamamoto, T; Yonemura, K | 1 |
Brito-Babapulle, F; Fielden, J; Rechner, I | 1 |
Fujimori, Y; Hara, H; Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T | 1 |
Matsouka, P; Monastirli, A; Pasmatzi, E; Tsambaos, D | 1 |
Boccadoro, M; Campa, E; Dellacasa, C; Fava, C; Ferrero, D; Fumagalli, M; Mattioli, G; Perfetti, P; Pogliani, EM; Rege-Cambrin, G | 1 |
Chao, TY; Chen, CH; Liu, FC | 1 |
Dong, M; Lin, Q; Wang, QM; Wen, JY; Wu, XY | 1 |
Bowden, R; Longton, G; Pepe, M; Sayer, HG; Storb, R | 1 |
Amylon, MD; Chao, NJ; Long, GD; Nademanee, AP; Negrin, RS; O'Donnell, MR; Parker, PM; Smith, EP; Snyder, DS; Stein, AS | 1 |
Amos, TA; Goldman, JM; Gooding, RP; Gordon, MY; Grand, FH; Lewis, JL | 1 |
Furuya, H; Hatazoe, T; Ishikura, H; Kato, Y; Ohguni, S; Sato, T; Tanaka, J; Tsumori, M; Wakayama, T | 1 |
Atkins, HL; Curtis, JE; Lipton, JH; Messner, HA; Minden, MD | 1 |
Adachi, M; Hinoda, Y; Horiuchi, S; Imai, K; Kimura, H; Mita, H; Takahashi, T; Tanimura, A; Yoshida, M | 1 |
Adkins, D; Brown, R; DiPersio, JF; Goodnough, LT; Khoury, H; Trinkaus, K; Vij, R; Westervelt, P | 1 |
Hasegawa, Y; Iwata, H; Kodera, Y; Kubo, T; Minami, S; Morishita, Y; Torii, Y; Yamada, Y | 1 |
Hojo, H; Ito, M; Kikuta, A; Nemoto, K; Ohto, H; Sano, H | 1 |
Essell, JH; Halvorson, RD; Harman, GS; Johnson, RA; Rubinsak, JR; Snyder, MJ; Thompson, JM | 1 |
Bello López, JL; Fonseca, E; Manso, F | 1 |
Trials
4 trial(s) available for methylprednisolone and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
Treatment of blastic phase chronic myeloid leukemia with mitoxantrone, cytosine arabinoside and high dose methylprednisolone.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Remission Induction; Survival Analysis; Treatment Outcome | 2002 |
Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention.
Topics: Anemia, Aplastic; Bacteremia; Bacterial Infections; Bone Marrow Transplantation; Candidiasis; Female; Fungemia; Graft vs Host Disease; Histocompatibility Testing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Myelodysplastic Syndromes; Regression Analysis; Risk Factors; Sepsis; Whole-Body Irradiation | 1994 |
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Chromosome Aberrations; Chromosome Disorders; Cyclosporine; Cytogenetics; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Methylprednisolone; Middle Aged; Recurrence; Survival Rate; Whole-Body Irradiation | 1994 |
Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide.
Topics: Actuarial Analysis; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Female; Follow-Up Studies; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Whole-Body Irradiation | 1992 |
Other Studies
18 other study(ies) available for methylprednisolone and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
Atypical Chronic Myeloid Leukemia in a Patient with Aplastic Anemia.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Etoposide; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Prednisolone; Pyridazines | 2019 |
Successful administration of cytarabine in a 16-month-old girl with acute myelogenous leukemia and cytarabine syndrome.
Topics: Cytarabine; Diphenhydramine; Drug Hypersensitivity; Female; Histamine Antagonists; Humans; Immunosuppressive Agents; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methylprednisolone; Premedication; Ranitidine; Syndrome; Treatment Outcome | 2009 |
The combination of thymosin and methylprednisolone for the treatment of a patient with colonic ulcers, subcutaneous nodules, and pleural effusion after dasatinib treatment for chronic myeloid leukemia.
Topics: Aged; Anti-Inflammatory Agents; Colonic Diseases; Dasatinib; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Pleural Effusion; Prognosis; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Subcutaneous Tissue; Thiazoles; Thymosin; Treatment Outcome; Ulcer | 2010 |
Withdrawal of interferon-alpha results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-alpha.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hemolysis; Hemolytic-Uremic Syndrome; Humans; Hydroxyurea; Interferon-alpha; Kidney Failure, Chronic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Middle Aged; Plasma Exchange; Pulse Therapy, Drug; Renal Dialysis; Thrombocytopenia | 2003 |
Systemic capillary leak syndrome after granulocyte colony-stimulating factor (G-CSF).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capillary Leak Syndrome; Combined Modality Therapy; Critical Care; Cyclophosphamide; Dexamethasone; Doxorubicin; Dyspnea; Edema; Fasciitis, Necrotizing; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Middle Aged; Models, Biological; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Thalidomide; Vasculitis, Leukocytoclastic, Cutaneous; Vincristine | 2003 |
Prognostic value of cyclic GMP in patients undergoing allogeneic bone marrow transplantation after conditioning with total body irradiation.
Topics: Adolescent; Adult; Biomarkers; Blast Crisis; Bone Marrow Transplantation; Cyclic GMP; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Monitoring, Physiologic; Myelodysplastic Syndromes; Neoplasm Staging; Nitric Oxide; Prognosis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2003 |
Disseminated erythematous and pityriasiform plaques caused by imatinib mesylate.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Benzamides; Erythema; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methylprednisolone; Middle Aged; Piperazines; Pityriasis; Pyrimidines | 2003 |
Corticosteroids can reverse severe imatinib-induced hepatotoxicity.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Benzamides; Chemical and Drug Induced Liver Injury; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Liver Diseases; Methylprednisolone; Piperazines; Prednisone; Pyrimidines | 2006 |
Polymyositis complicating donor lymphocyte infusion after stem cell transplantation for relapsed chronic myeloid leukemia: report of a case and review of literature.
Topics: Adult; Combined Modality Therapy; Glucocorticoids; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Transfusion; Male; Methylprednisolone; Polymyositis; Pulse Therapy, Drug; Recurrence; Stem Cell Transplantation | 2007 |
[Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
Topics: Adolescent; Adult; Child; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Graft vs Host Reaction; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Middle Aged; Proportional Hazards Models; Recurrence; Retrospective Studies; Survivors; Transplantation, Homologous | 2006 |
Apoptosis in chronic myeloid leukaemia: normal responses by progenitor cells to growth factor deprivation, X-irradiation and glucocorticoids.
Topics: Apoptosis; Cell Survival; Cells, Cultured; Dose-Response Relationship, Radiation; Erythroid Precursor Cells; Growth Substances; Humans; Hydrocortisone; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methylprednisolone | 1995 |
[Treatment with bolus methylprednisolone for pure red cell aplasia after ABO incompatible bone marrow transplantation in a patient with chronic myelocytic leukemia].
Topics: ABO Blood-Group System; Adult; Anti-Inflammatory Agents; Blood Group Incompatibility; Bone Marrow Transplantation; Drug Administration Schedule; Humans; Injections, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Red-Cell Aplasia, Pure; Transplantation, Homologous | 1995 |
Intensive remission induction therapy for chronic myeloid leukemia in blast phase with a goal of post-remission bone marrow transplant--a pilot study.
Topics: Adolescent; Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Transplantation; Etoposide; Female; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Pilot Projects; Remission Induction; Survival Rate; Vincristine | 1996 |
[An allogeneic bone marrow transplantation for chronic myelocytic leukemia with a large extramedullary tumor in the pelvic cavity].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Dexamethasone; Female; Follow-Up Studies; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Methylprednisolone; Pelvis; Transplantation, Homologous | 1996 |
Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation.
Topics: Adult; Cyclophosphamide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Middle Aged; Nuclear Family; Transplantation, Homologous; Whole-Body Irradiation | 2000 |
Osteonecrosis of the femoral head after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Age Factors; Anemia, Aplastic; Bone Marrow Transplantation; Chi-Square Distribution; Female; Femur Head Necrosis; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Injections, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Logistic Models; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiography; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Transplantation, Homologous | 2001 |
[Successful treatment with combined anti-thymocyte globulin and methylprednisolone for bronchiolitis obliterans after allogeneic bone marrow transplantation in a child with chronic myelogenous leukemia].
Topics: Anti-Inflammatory Agents; Antilymphocyte Serum; Bone Marrow Transplantation; Bronchiolitis Obliterans; Child; Drug Therapy, Combination; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Postoperative Complications | 2002 |
Sweet's syndrome during the chronic phase of chronic myeloid leukaemia.
Topics: Drug Therapy, Combination; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Leukocytosis; Male; Methylprednisolone; Middle Aged; Naproxen; Neutrophils; Skin Diseases; Syndrome | 1990 |